{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:12:32Z","timestamp":1782997952840,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002403","name":"Taibah University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002403","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.biopha.2017.11.028","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T12:37:17Z","timestamp":1510835837000},"page":"1356-1365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Esomeprazole ameliorates CCl4 induced liver fibrosis in rats via modulating oxidative stress, inflammatory, fibrogenic and apoptotic markers"],"prefix":"10.1016","volume":"97","author":[{"given":"Heba M.","family":"Eltahir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiiada H.","family":"Nazmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.biopha.2017.11.028_bib0005","first-page":"S84","article-title":"Hepatic stellate cells and the reversal of fibrosis","volume":"21","author":"Kisseleva","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.biopha.2017.11.028_bib0010","first-page":"d69","article-title":"Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell","author":"Gabele","year":"2003","journal-title":"Front. Biosci."},{"issue":"5","key":"10.1016\/j.biopha.2017.11.028_bib0015","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.028_bib0020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jep.2009.09.009","article-title":"The hepatoprotective and antifibrotic effects of Saururus chinensis against carbon tetrachloride induced hepatic fibrosis in rats","volume":"126","author":"Wang","year":"2009","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.028_bib0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.taap.2011.02.004","article-title":"Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis","volume":"252","author":"Shaker","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.028_bib0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/713611034","article-title":"Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model","volume":"33","author":"Weber","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"issue":"1-2","key":"10.1016\/j.biopha.2017.11.028_bib0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11010-015-2572-2","article-title":"Experimental evidence for the therapeutic potential of tempol in the treatment of acute liver injury","volume":"411","author":"Abouzied","year":"2016","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.028_bib0040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0014-4800(03)00097-2","article-title":"Oxidative stress, toxic hepatitis, and antioxidants with particular emphasis on zinc","volume":"75","author":"Stehbens","year":"2003","journal-title":"Exp. Mol. Pathol."},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2017.11.028_bib0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1365-2036.2000.014s1074.x","article-title":"A new mechanism for anti-inflammatory actions of proton pump inhibitors\u2013inhibitory effects on neutrophil-endothelial cell interactions","volume":"14","author":"Yoshida","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.028_bib0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5009\/gnl15502","article-title":"25 years of proton pump inhibitors: a comprehensive review","volume":"11","author":"Strand","year":"2017","journal-title":"Gut Liver"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2017.11.028_bib0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000091298","article-title":"Acid suppression therapy: where do we go from here?","volume":"24","author":"Scarpignato","year":"2006","journal-title":"Dig. Dis."},{"issue":"9\u201310","key":"10.1016\/j.biopha.2017.11.028_bib0060","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s002280000206","article-title":"Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects","volume":"56","author":"Hassan-Alin","year":"2000","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.028_bib0065","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1365-2036.2003.01481.x","article-title":"Review article: esomeprazole--enhanced bio-availability, specificity for the proton pump and inhibition of acid secretion","volume":"17","author":"Lindberg","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.028_bib0070","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.dld.2008.10.004","article-title":"Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment","volume":"41","author":"Colucci","year":"2009","journal-title":"Dig. Liver Dis."},{"issue":"13","key":"10.1016\/j.biopha.2017.11.028_bib0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12967-015-0614-x","article-title":"Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis","author":"Ghebremariam","year":"2015","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.028_bib0080","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21060698","article-title":"Metabolic profile changes of CCl(4)-liver fibrosis and inhibitory effects of Jiaqi Ganxian granule","volume":"21","author":"Wang","year":"2016","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.biopha.2017.11.028_bib0085","first-page":"443","article-title":"Evaluation of anti-ulcer activity of esomeprazole magnesium trihydrate film in wistar rats with gastric ulceration induced by Indomethacin","volume":"3","author":"Narwal","year":"2016","journal-title":"EJPM"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.028_bib0090","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s12906-016-1398-0","article-title":"Protective effects of Fraxinus xanthoxyloides (Wall.) leaves against CCl4 induced hepatic toxicity in rat","volume":"16","author":"Younis","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.028_bib0095","first-page":"283","article-title":"Studies on lipid peroxides in platelets. I. Method of assay and effect of storage","volume":"75","author":"Okuma","year":"1970","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.biopha.2017.11.028_bib0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0076-6879(94)34095-1","article-title":"Total antioxidant status in plasma and body fluids","volume":"234","author":"Rice-Evans","year":"1994","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.biopha.2017.11.028_bib0105","series-title":"CRC Handbook of Methods of Oxygen Radicals Research","article-title":"Catalase Activity","author":"Claiborne","year":"1985"},{"issue":"3","key":"10.1016\/j.biopha.2017.11.028_bib0110","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s13277-014-2778-z","article-title":"Curcumin ameliorate DENA-induced HCC via modulating TGF-beta, AKT, and caspase-3 expression in experimental rat model","volume":"36","author":"Abouzied","year":"2015","journal-title":"Tumour Biol."},{"issue":"16","key":"10.1016\/j.biopha.2017.11.028_bib0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12906-016-1238-2","article-title":"Hepatoprotective activity of ethanolic extract of Salix subserrata against CCl4-induced chronic hepatotoxicity in rats","author":"Wahid","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.028_bib0120","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","article-title":"Grading and staging systems for inflammation and fibrosis in chronic liver diseases","volume":"47","author":"Goodman","year":"2007","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.028_bib0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cbi.2011.07.001","article-title":"Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches","volume":"193","author":"Mormone","year":"2011","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.biopha.2017.11.028_bib0130","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","article-title":"Clinical evidence for the regression of liver fibrosis","volume":"56","author":"Ellis","year":"2012","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.028_bib0135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2131\/jts.41.561","article-title":"Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis","volume":"41","author":"Dong","year":"2016","journal-title":"J. Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.028_bib0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-2008-1040454","article-title":"Cellular sources of collagen and regulation of collagen production in liver","volume":"10","author":"Friedman","year":"1990","journal-title":"Semin. Liver Dis."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.028_bib0145","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/08977198908997998","article-title":"Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in acute liver injury","volume":"1","author":"Czaja","year":"1989","journal-title":"Growth Factors"},{"issue":"4","key":"10.1016\/j.biopha.2017.11.028_bib0150","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840110412","article-title":"Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis","volume":"11","author":"Matsuoka","year":"1990","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2017.11.028_bib0155","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/0006-291X(90)90801-S","article-title":"Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type beta 1 and type alpha","volume":"171","author":"Meyer","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2017.11.028_bib0160","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10620-005-2668-8","article-title":"Production of pro- and anti-fibrotic agents by rat Kupffer cells; the effect of octreotide","volume":"50","author":"Xidakis","year":"2005","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.028_bib0165","doi-asserted-by":"crossref","first-page":"G1093","DOI":"10.1152\/ajpgi.00292.2009","article-title":"Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis","volume":"297","author":"Choi","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.028_bib0170","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/hep.23931","article-title":"E-cadherin antagonizes transforming growth factor beta1 gene induction in hepatic stellate cells by inhibiting RhoA-dependent Smad3 phosphorylation","volume":"52","author":"Cho","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biopha.2017.11.028_bib0175","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/1756283X11413002","article-title":"Current status of novel antifibrotic therapies in patients with chronic liver disease","volume":"4","author":"Cohen-Naftaly","year":"2011","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.028_bib0180","doi-asserted-by":"crossref","first-page":"806","DOI":"10.18203\/2320-6012.ijrms20170501","article-title":"Hepatoprotective effect of aqueous extract of Melothria perpusilla against carbon tetrachloride induced liver injury in albino rats","volume":"5","author":"Yengkhom","year":"2017","journal-title":"Int. J. Res. Med. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.028_bib0185","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0929-693X(01)00800-4","article-title":"Mechanisms of hepatic fibrogenesis","volume":"9","author":"Lamireau","year":"2002","journal-title":"Arch. Pediatr."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.028_bib0190","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1006\/taap.2001.9304","article-title":"The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride","volume":"177","author":"Simeonova","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.028_bib0195","doi-asserted-by":"crossref","first-page":"e65251","DOI":"10.1371\/journal.pone.0065251","article-title":"Tumor necrosis factor-alpha promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells","volume":"8","author":"Osawa","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2017.11.028_bib0200","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1152\/physrev.00061.2009","article-title":"Hepatocyte death: a clear and present danger","volume":"90","author":"Malhi","year":"2010","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.028_bib0205","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0002-9440(10)65594-0","article-title":"Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride","volume":"153","author":"Shi","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"5517","key":"10.1016\/j.biopha.2017.11.028_bib0210","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1126\/science.292.5517.624","article-title":"The mitochondrion: is it central to apoptosis?","volume":"292","author":"Finkel","year":"2001","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.028_bib0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12916-016-0718-z","article-title":"Effective and safe proton pump inhibitor therapy in acid-related diseases\u2014a position paper addressing benefits and potential harms of acid suppression","volume":"14","author":"Scarpignato","year":"2016","journal-title":"BMC Med."},{"issue":"11","key":"10.1016\/j.biopha.2017.11.028_bib0220","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s10620-009-0951-9","article-title":"Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications","volume":"54","author":"Kedika","year":"2009","journal-title":"Dig. Dis. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2017.11.028_bib0225","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00011-006-6056-4","article-title":"Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors","volume":"55","author":"Handa","year":"2006","journal-title":"Inflamm. Res."},{"issue":"9","key":"10.1016\/j.biopha.2017.11.028_bib0230","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jnutbio.2004.03.003","article-title":"Effect of the H, K-ATPase inhibitor, esomeprazole magnesium, on gut total antioxidant capacity in mice","volume":"15","author":"Koch","year":"2004","journal-title":"J. Nutr. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.028_bib0235","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00210-008-0314-7","article-title":"Effects of esomeprazole on glutathione levels and mitochondrial oxidative phosphorylation in the gastric mucosa of rats treated with indomethacin","volume":"378","author":"Pastoris","year":"2008","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.028_bib0240","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.bbrc.2006.04.170","article-title":"Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells","volume":"345","author":"Becker","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.028_bib0245","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2710.2008.00907.x","article-title":"A succinct review of the general and immunological pharmacologic effects of proton pump inhibitors","volume":"33","author":"Namazi","year":"2008","journal-title":"J. Clin. Pharm. Ther."},{"issue":"13","key":"10.1016\/j.biopha.2017.11.028_bib0250","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1074\/jbc.M210328200","article-title":"A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical","volume":"278","author":"Biswas","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.biopha.2017.11.028_bib0255","doi-asserted-by":"crossref","first-page":"14391","DOI":"10.1074\/jbc.M800414200","article-title":"Lansoprazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal","volume":"283","author":"Maity","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.028_bib0260","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/138920112798868818","article-title":"Silymarin in the prevention and treatment of liver diseases and primary liver cancer","volume":"13","author":"Feher","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.028_bib0265","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/antiox4010204","article-title":"Silymarin as a natural antioxidant: an overview of the current evidence and perspectives","volume":"4","author":"Surai","year":"2015","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"10.1016\/j.biopha.2017.11.028_bib0270","first-page":"491","article-title":"Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine","volume":"124","author":"Pradhan","year":"2006","journal-title":"Indian J. Med. Res."},{"issue":"5","key":"10.1016\/j.biopha.2017.11.028_bib0275","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1053\/j.gastro.2007.02.038","article-title":"Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin","volume":"132","author":"Polyak","year":"2007","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.biopha.2017.11.028_bib0280","first-page":"1","article-title":"Hepatoprotective effect of oral application of a silymarin extract in carbon tetrachloride-induced hepatotoxicity in rats","volume":"1","author":"Mahli","year":"2015","journal-title":"Clin. Phytosci."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217334741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217334741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:26:11Z","timestamp":1780338371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217334741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":56,"alternative-id":["S0753332217334741"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.11.028","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Esomeprazole ameliorates CCl4 induced liver fibrosis in rats via modulating oxidative stress, inflammatory, fibrogenic and apoptotic markers","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}